{"organizations": [], "uuid": "c1f8eaafbc8003d971ed462a6af902c829bb2e95", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-pernix-announces-patent-litigation/brief-pernix-announces-patent-litigation-settlement-agreement-with-actavis-idUSFWN1PO0XD", "country": "US", "domain_rank": 408, "title": "BRIEF-Pernix Announces Patent Litigation Settlement Agreement With Actavis", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-29T15:16:00.000+02:00", "replies_count": 0, "uuid": "c1f8eaafbc8003d971ed462a6af902c829bb2e95"}, "author": "", "url": "https://www.reuters.com/article/brief-pernix-announces-patent-litigation/brief-pernix-announces-patent-litigation-settlement-agreement-with-actavis-idUSFWN1PO0XD", "ord_in_thread": 0, "title": "BRIEF-Pernix Announces Patent Litigation Settlement Agreement With Actavis", "locations": [], "entities": {"persons": [{"name": "alvogen", "sentiment": "none"}], "locations": [{"name": "malta", "sentiment": "none"}], "organizations": [{"name": "pernix therapeutics holdings inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "gainesville llc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 16 PM / in 12 minutes BRIEF-Pernix Announces Patent Litigation Settlement Agreement With Actavis Reuters Staff \nJan 29 (Reuters) - Pernix Therapeutics Holdings Inc: \n* PERNIX ANNOUNCES PATENT LITIGATION SETTLEMENT AGREEMENT WITH ACTAVIS CONCERNING ZOHYDRO® ER \n* PERNIX - UNDER TERMS, CO TO GRANT ACTAVIS LICENSE FOR SELLING A GENERIC VERSION OF ZOHYDRO(®) ER ON MARCH 1, 2029, OR EARLIER UNDER SOME CIRCUMSTANCES‍​‍​ \n* PERNIX - SETTLEMENT AGREEMENT ALSO RESOLVES A PENDING APPEAL RELATED TO A PATENT LITIGATION BETWEEN RECRO GAINESVILLE LLC AND ACTAVIS‍​ \n* PERNIX THERAPEUTICS HOLDINGS INC - OTHER DETAILS OF SETTLEMENT WITH ACTAVIS CONCERNING ZOHYDRO ER ARE CONFIDENTIAL \n* PERNIX-PATENT LITIGATION BROUGHT BY CO AGAINST ALVOGEN MALTA OPERATIONS RELATED TO ALVOGEN’S PROPOSED GENERIC VERSION OF ZOHYDRO(®) ER REMAINS PENDING‍​  ", "external_links": [], "published": "2018-01-29T15:16:00.000+02:00", "crawled": "2018-01-29T15:33:03.008+02:00", "highlightTitle": ""}